-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Azitra (AMEX:AZTR) shares rose 86.5% to $0.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.9 million.
  • uniQure (NASDAQ:QURE) stock moved upwards by 74.1% to $46.99. The company's market cap stands at $1.7 billion.
  • Lunai Bioworks (NASDAQ:LNAI) stock increased by 63.44% to $4.65. The market value of their outstanding shares is at $12.8 million.
  • NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 40.07% to $0.98. The market value of their outstanding shares is at $1.9 million.
  • ClearPoint Neuro (NASDAQ:CLPT) shares rose 31.18% to $17.5. The market value of their outstanding shares is at $400.0 million.
  • Eloxx Pharma (NASDAQ:ELOX) shares increased by 13.72% to $14.5. The company's market cap stands at $43.8 million.

Losers

  • Aditxt (NASDAQ:ADTX) stock declined by 29.4% to $0.01 during Wednesday's pre-market session.
  • IM Cannabis (NASDAQ:IMCC) stock declined by 15.39% to $0.22. The market value of their outstanding shares is at $2.3 million.
  • CervoMed (NASDAQ:CRVO) shares decreased by 11.87% to $3.98. The company's market cap stands at $41.8 million.
  • Avalo Therapeutics (NASDAQ:AVTX) stock declined by 11.38% to $12.7. The company's market cap stands at $753.2 million.
  • iTonic Holdings (NASDAQ:ITOC) shares declined by 11.25% to $0.31. The market value of their outstanding shares is at $6.0 million.
  • bioAffinity Technologies (NASDAQ:BIAF) stock decreased by 11.11% to $0.84. The company's market cap stands at $4.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending